 differenti respons malign human b-cell anti-igm immunoglobulin anti-mu b-cell growth factor uniqu direct cytotox anti-mu prolymphocyt leukemia cell vitro thymidin uptak cell prolymphocyt leukemia pll chronic lymphocyt leukemia cll plasma cell leukemia pcl patient respons cultur anti-human igm antibodi anti-mu b-cell growth factor bcgf contrast stimulatori effect normal b-cell cultur dival anti-mu antibodi autonom prolifer cytotox pll cell cultur independ complement fc-receptor-medi mechan stimul inhibit slgm+ cll slgm- pcl cell inhibitori effect pll cell anti-mu concentr stimulatori threshold normal cell signific impair trypan blue exclus hour morpholog cellular chang program cell death mechan apoptosi cytotox independ slgm-stain intens autonom bcgf-augment dna synthet activ pll cell similar patient pll prolymphocyt transform cll cell pll patient elutri fraction bcgf-unrespons larg cell fraction mark autonom dna synthesi lymphoid cell low uptak bcgf fraction suscept cytotox effect anti-mu data certain slgm-bear malign cell suscept anti-mu-trigg cytotox malign counterpart tolerogen normal b-cell subset uniqu direct cytotox anti-mu therapeut strategi pll